Health Care

GE selling off biopharma business in $21.4B deal

GE selling off biopharma business in $21.4B deal”

General Electric (GE) announced on Monday it will sell its Biopharma unit to Danaher for $21.4 billion in cash as it reduces debt amid an ongoing corporate turnaround effort.

The valuation multiples "look reasonable for a market-leading, high-end life sciences business like GE Biopharma", Dray said.

Shares in GE surged Monday, rising nearly 9% to their highest level since October 2018.

Culp told CNBC that while an IPO for the healthcare business was plan A, "this is clearly a superior path", as it gives the company a quick route to paying down debt.

- The shares have advanced 34 per cent this year through February 22, the biggest gain on a Standard & Poor's index of USA industrial companies. "We expect GE BioPharma to advance our growth and innovation strategy in an important and highly attractive life science market", Danaher CEO Thomas Joyce said.

More news: HTC Now Banks On 5G Hub After Struggling With Smartphones

William Blair's William Heymann reiterated a Buy rating and writes that GE's intrinsic value lies somewhere between $14 and $16 a share.

Danaher develops technology for the dental, life sciences, diagnostics and environmental industries. The company divested this unit to "reduce leverage and strengthen [its] balance sheet", Lawrence Culp Jr., GE chairman and CEO, said in a press release.

Danaher and General Electric are expecting the deal for GE Biopharma to close during the fourth quarter of 2019. GE will receive cash proceeds of about $21 billion while also transferring certain pension liabilities to Danaher. "It lost two-thirds of its market value in the last two years amid a series of operational and investment missteps". That will leave GE with a US$17 billion business manufacturing MRI machines and other imaging equipment.

Instead, the company will prioritize completing the Danaher deal while retaining the rest of its healthcare unit. After being named as the new CEO last fall, Larry Culp said GE needed to simplify its business structure even more. It makes instruments and software that support the research and development of drugs, accounting for 15% of GE's healthcare business revenue in 2018. Such substances, or contrast agents, from GE are used in about 90 million patient procedures each year, according to the company's statement.

GE said this month that it would downsize its world headquarters in Boston and return $87 million in incentives it received from MA for moving from CT three years ago. The company also reported, though, that cash flow from operations was down 8.6% year over year, to about $6.4 billion. "That's what took the stock down, and that's still going to take some time play out", said Richard Grasfeder, a portfolio manager at Boston Private Wealth LLC, which held about 478,204 shares in GE as of the end of 2018, down from 787,600 shares a year earlier.

Like this



27 February 2019
Russian TV lists potential nuclear strike targets in USA after Putin warning
The hypersonic missiles Kiselyov referred to in his news briefing can travel at more than five times the speed of sound. Asked to comment on Kiselyov's report, the Kremlin said on Monday it did not interfere in state TV's editorial policy.

27 February 2019
Deontay Wilder has stopped texting Tyson Fury back
The British challenger even publicly stated he would not let " boxing politics" stand in the way of fighting Wilder. That fight would have crowned an "interim" WBC champion with the victor going on to face Wilder or Fury.

27 February 2019
Stefanos Tsitsipas claims Open 13 Provence title in Marseille
He is hopeful that he will be able to win his first ATP Tour final since his maiden title at the St Petersburg Open nine years ago. "There is no better feeling than winning a title".

27 February 2019
Global stocks rise after Trump tariff extension
China proposed last week in talks to increase purchases of US commodities by $30 billion a year more than pre-trade war levels. The market will always react to trans-continental trade, said John Monaco, a trader at Wellington Shields & Co.

27 February 2019
Elon Musk's Tweets Aren't Making the SEC Happy
Even after the Tweet that finally prompted the SEC into action against Musk, the billionaire doubled down against them. The SEC deemed these statements "false and misleading" and sued the Tesla and SpaceX chief in September.

27 February 2019
Hotter Volkswagen T-Roc R SUV revealed
In addition, the adapted underbody guard in the same colour as the trim and the specific air inlets are typical of the "R" design. The Electronic Stability Control feature can be manually switched off to ensure particularly dynamic driving on the edge.

27 February 2019
Two new measles cases in Vancouver as outbreak spreads to Edmonton
The mom wanted people to know that this person visited Delta Hospital on Feb. 17 and Feb. 20 and was also at St. At a news conference Monday, Vancouver Coastal Health said no new cases have been reported since the weekend.

27 February 2019
Everything you know about the Huawei P30 Pro could be wrong
You can find him at your local pro wrestling events, and wondering why Apple made a decision to ditch its MagSafe power adapters. Naturally, as it is basically the signature feature on the Matebook X Pro , the pop-up selfie camera makes a reappearance.

27 February 2019
Fortnite Season 8 start date CONFIRMED as Epic teaser promises bananas
Or maybe that's Epic Games' version of a dragon, really anything could happen. Developer Epic Games revealed this with a tweet yesterday.

26 February 2019
Air strike on Pakistan sparks celebrations in India, seen boosting Modi support
Kashmir has been divided between Pakistan and India since the end of British colonial rule over the subcontinent in 1947. It is located about 50km (30 miles) from the Line of Control (LoC) in the disputed region of Kashmir.